SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ImmunityBio Shares Face Weekly Loss Despite Anktiva FDA Approval

ImmunityBio shares are on track for a weekly loss despite broader U.S. approval for Anktiva on Wednesday. Investors are awaiting founder Patrick Soon-Shiong’s trial discussion on Friday.

IBRX
SquawkNews Desk

Related stories

Reddit Shares Plunge 18% After Revenue Outlook Misses Expectations Reddit shares fell about 18% in after-hours trading in New York after the company said it would limit unregistered users’ access to its platform and issued a revenue outlook below M impact | EQUITY | Oct 30, 2026, 01:51 AM UTC Kingsgate Consolidated Reports Quarterly Gold and Silver Sales Kingsgate Consolidated reported gold sales of 17,339 ounces and silver sales of 211,081 ounces for the quarter. M impact | EQUITY | Oct 30, 2026, 01:46 AM UTC Kingsgate Consolidated Produces 14,802 Ounces of Gold and 187,925 Ounces of Silver The company reported an all-in sustaining cost of US$1,547 per ounce and said the metals were sold in the quarter. L impact | EQUITY | Oct 30, 2026, 01:46 AM UTC China’s Xinyi Sheng Drops 15.1% as Q3 Net Profit Falls Xinyi Sheng shares fell as much as 15.1% Friday morning after its third-quarter net profit declined nearly one-fifth quarter over quarter. M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC Mastercard Shares Rise More Than 4% After Q3 Results Beat Expectations Mastercard shares gained more than 4% at Thursday’s close, reached a 52-week high of $641.56 during regular trading and logged their best session since January. M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC Hyundai Glovis Q3 Operating Profit Rises 8.1% Hyundai Glovis reported an 8.1% year-on-year rise in third-quarter operating profit. M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC